Hexarelin

This page shows anti-doping rule violation data we have registered for Hexarelin.

Number of cases in Hexarelin Last 10 Years

Hexarelin

Hexarelin ranks #254 globally among prohibited substances, with 2 registered cases (0% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,710 verified cases. Slovakia leads with 1 cases, while Bodybuilding is the most affected sport (1 cases).

Cases of Hexarelin by Sport
Bodybuilding
1
Australian Football
1
Top Sport: Bodybuilding

1

Bodybuilding cases

0%

Of all violations

2

Total Hexarelin cases
Bodybuilding's share of Hexarelin violations 0%
1 of 2

Bodybuilding has the most recorded cases of Hexarelin violations globally, with 1 registered cases — 0% of all 2 verified cases.

Cases of Hexarelin by Country
Slovakia
1
Australia
1
Top Country: Slovakia

1

Slovakia cases

50%

Of all violations

2

Total Hexarelin cases
Slovakia's share of Hexarelin violations 50%
1 of 2

Slovakia dominates Hexarelin violations globally, with 1 registered cases — 50% of all 2 verified cases.

Global Substance Ranking

Hexarelin ranks #254 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,364
#2 Methandienone
835
#3 Norandrosterone
781
#4 Testosterone
758
···
#254 Hexarelin
2
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 50%
1 cases
Female 50%
1 cases
Analysis: shows an unusually high proportion of female cases (50%) compared to the global average (19.8%), a difference of 30.2 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
48.7
months
Hexarelin
30.1
months
Global average

The average suspension for Hexarelin violations is 48.7 months, longer than the global average of 30.1 months.

Examorelin, also known as hexarelin, is a potent, synthetic, peptidic, orally-active, centrally-penetrant, and highly selective agonist of the ghrelin/growth hormone secretagogue receptor and a growth hormone secretagogue which was developed by Mediolanum Farmaceutici. (Source: Wikipedia)

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,710 verified anti-doping rule violations across all sports and all countries, and is updated regularly.